Search Results

MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) has announced today that they will be presenting at both the CEM Bahamas Small-Cap Conference, and Maxim Group’s 2024 Healthcare IT Conference in the upcoming week.

Bayer and Hologic, Inc. (Nasdaq: HOLX) today announced a first-of-its-kind collaboration to deliver a coordinated solution for contrast-enhanced mammography (CEM).

CEM Corporation and AmbioPharm, Inc. are excited to announce the formation of a partnership for production of GMP peptides for the global market.

Sirius Medical a global leader in Value-Based Healthcare and Surgical Marker Navigation, announced that GE HealthCare will showcase Pintuition at the upcoming Annual European Society of Breast Imaging (EUSOBI) Conference 2023.

There is a significant mismatch between the need for new antimicrobials and the traditional pharmaceutical business model.

CEM Corporation is proud to introduce the new Discover® 2.0 microwave synthesizer. The Discover 2.0 is a significant update to CEM’s existing Discover product line that is used in thousands of synthetic chemistry laboratories worldwide.

Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million.